LEADER 02438nam 2200565 a 450 001 9910789403103321 005 20200520144314.0 010 $a1-84973-301-5 035 $a(CKB)2670000000096425 035 $a(EBL)1185803 035 $a(OCoLC)746035479 035 $a(SSID)ssj0000578452 035 $a(PQKBManifestationID)12187324 035 $a(PQKBTitleCode)TC0000578452 035 $a(PQKBWorkID)10578627 035 $a(PQKB)11177410 035 $a(MiAaPQ)EBC1185803 035 $a(Au-PeEL)EBL1185803 035 $a(CaPaEBR)ebr10627712 035 $a(CaONFJC)MIL871756 035 $a(PPN)198466943 035 $a(EXLCZ)992670000000096425 100 $a20121212d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNeurodegeneration$b[electronic resource] $emetallostasis and proteostasis /$fedited by Danilo Milardi and Enrico Rizzarelli 210 $aCambridge $cRSC Pub.$d2011 215 $a1 online resource (285 p.) 225 1 $aRSC drug discovery series,$x2041-3203 ;$vno. 7 300 $aDescription based upon print version of record. 311 $a1-84973-050-4 320 $aIncludes bibliographical references and index. 327 $ai-iv; v-viii; xi-xiv; 1-17.PDF.pdf; 18-45; 46-68; 69-82; 83-111; 112-140; 141-151; 152-173; 174-211; 212-225; 226-248; 249-258; 259-270 330 $aSince Alois Alzheimer described the results of his postmortem studies in 1906, significant strides have been made in understanding the pathogenesis of neurodegenerative diseases. Substantial evidence has accumulated indicating that diverse neurodegenerative disorders might share a common pathological mechanism: the misfolding, aggregation and accumulation of proteins (termed ""amyloid"") in the brain. Metal ions have long been thought to catalyze protein misfolding initiating a cascade of events resulting in oxidative damage and neurodegeneration. They have, consequently, been seen as a suitab 410 0$aRSC drug discovery series ;$v7. 606 $aNervous system$xDegeneration 615 0$aNervous system$xDegeneration. 676 $a616.8047 701 $aMilardi$b Danilo$01487322 701 $aRizzarelli$b Enrico$01487323 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910789403103321 996 $aNeurodegeneration$93707115 997 $aUNINA